Abstract:
Dysbiotic changes in the gastroduodenal zone, as they progress, worsen the clinical course of the underlying disease, contributing to an increase in the atherogenic potential of blood serum. These circumstances predetermine the need to improve approaches to the correction of metabolic disorders in patients with reactive arthritis.